Diagnostic protein marker patterns in squamous cervical cancer
- 13 January 2010
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 4 (1) , 17-31
Abstract
Purpose: Cervical cancer is the second most prevalent malignancy of women. Our aim was to identify additional marker protein patterns for objective diagnosis of squamous cervical cancer (SCC).Experimental design: Collected tissue biopsies of SCC, squamous vaginal cancer (SVC), normal cervical and vaginal mucosa were subjected to 2‐DE, SameSpot analysis, MALDI‐TOF‐MS protein identification, and analysis of the expression of selected proteins by immunohistochemistry.Results: In 148 protein spots selected by the difference in expression 99 proteins were identified. A differential protein pattern for SCC was, e.g. over‐expressed (OE) eukaryotic translation initiation factor 3‐2β, neutrophil cytosolic factor 2, annexin A6 (ANXA6), for SVC it was OE cathepsin D, γ‐catenin, RAB2A, for both cancers it was OE apolipoprotein E, tropomyosin 3, HSPA8, and underexpressed cytokeratin 13, osteoglycin. In SCC nuclear expression of neutrophil cytosolic factor 2, PRDX2, HSP27 (nine of ten cases), ANXA6 (nine of ten cases) was observed while tropomyosin 4 was expressed only in two of ten cases. There was 81.1% (43/53) agreement between the expression of protein spots and the immune expression of proteins (www.proteinatlas.org).Conclusions and clinical relevance: SCC is characterized by specific tissue marker protein patterns that allow objective detection of the disease. They can become a basis for objective automated cytology‐based screening and improve current diagnostics of SCC.Keywords
Funding Information
- Swedish Cancer Foundation (070623, CAN 2007/1044)
- KI Cancer Strategic Grants (5888/05-722)
- Swedish Research Council (521-2008-2899)
- Medical Research Council
- Cancer Society in Stockholm, Stockholm County Council, Swedish Labour Market Insurance
- EU-grant FLUODIAMON
This publication has 38 references indexed in Scilit:
- Papillomaviruses in the causation of human cancers — a brief historical accountVirology, 2009
- Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and DeterminantsCancer Epidemiology, Biomarkers & Prevention, 2009
- The Accuracy of the Papanicolaou Smear in the Screening and Diagnostic SettingsJournal of Lower Genital Tract Disease, 2008
- Natural history and epidemiology of HPV infection and cervical cancerGynecologic Oncology, 2008
- Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infectionScandinavian Journal of Infectious Diseases, 2008
- A Longitudinal Swedish Study on Screening for Squamous Cell Carcinoma and Adenocarcinoma: Evidence of Effectiveness and OvertreatmentCancer Epidemiology, Biomarkers & Prevention, 2007
- Immunocytochemical detection of HPV16 E7 in cervical smearExperimental & Molecular Medicine, 2007
- Papanicolaou smear history in women with low-grade cytology before cervical cancer diagnosisCancer, 2007
- Synergy between Cigarette Smoking and Human Papillomavirus Type 16 in Cervical Cancer In situ DevelopmentCancer Epidemiology, Biomarkers & Prevention, 2006
- Obstacles to the Early Detection of Endocervical AdenocarcinomaInternational Journal of Gynecological Pathology, 2005